Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?
Article in European Journal of Clinical Pharmacology (February 2024)
The most recent citing publications are shown below. View all 114 publications that cite this research output on Dimensions.
Article in European Journal of Clinical Pharmacology (February 2024)
Article in Canadian Family Physician (June 2023)
Book chapter (January 2023)